Literature DB >> 29805078

Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.

Begoña Cánovas1, Ana Igea1, Alessandro A Sartori2, Roger R Gomis3, Tanya T Paull4, Michitaka Isoda1, Héctor Pérez-Montoyo5, Violeta Serra6, Eva González-Suárez5, Travis H Stracker1, Angel R Nebreda7.   

Abstract

Breast cancer is the second leading cause of cancer-related death among women. Here we report a role for the protein kinase p38α in coordinating the DNA damage response and limiting chromosome instability during breast tumor progression, and identify the DNA repair regulator CtIP as a p38α substrate. Accordingly, decreased p38α signaling results in impaired ATR activation and homologous recombination repair, with concomitant increases in replication stress, DNA damage, and chromosome instability, leading to cancer cell death and tumor regression. Moreover, we show that pharmacological inhibition of p38α potentiates the effects of taxanes by boosting chromosome instability in murine models and patient-derived xenografts, suggesting the potential interest of combining p38α inhibitors with chemotherapeutic drugs that induce chromosome instability.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CtIP; DNA damage response; DNA repair; breast cancer; chemotherapy; chromosome instability; p38α; pharmacological inhibitor; replication stress; taxanes

Mesh:

Substances:

Year:  2018        PMID: 29805078     DOI: 10.1016/j.ccell.2018.04.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  28 in total

1.  Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss.

Authors:  Bhavna Murali; Qihao Ren; Xianmin Luo; Douglas V Faget; Chun Wang; Radia Marie Johnson; Tina Gruosso; Kevin C Flanagan; Yujie Fu; Kathleen Leahy; Elise Alspach; Xinming Su; Michael H Ross; Barry Burnette; Katherine N Weilbaecher; Morag Park; Gabriel Mbalaviele; Joseph B Monahan; Sheila A Stewart
Journal:  Cancer Res       Date:  2018-08-09       Impact factor: 12.701

2.  From tumorigenesis to cell death: the aneuploidy paradox.

Authors:  Sylvie Rodrigues-Ferreira; Clara Nahmias
Journal:  Mol Cell Oncol       Date:  2020-01-16

Review 3.  Chromosome Missegregation as a Modulator of Radiation Sensitivity.

Authors:  Pippa F Cosper; Sarah E Copeland; John B Tucker; Beth A Weaver
Journal:  Semin Radiat Oncol       Date:  2022-01       Impact factor: 5.934

4.  Mapping p38α mitogen-activated protein kinase signaling by proximity-dependent labeling.

Authors:  Emmanuel Prikas; Anne Poljak; Arne Ittner
Journal:  Protein Sci       Date:  2020-04-07       Impact factor: 6.725

Review 5.  Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process.

Authors:  Massimo Pancione; Luigi Cerulo; Andrea Remo; Guido Giordano; Álvaro Gutierrez-Uzquiza; Paloma Bragado; Almudena Porras
Journal:  Biomolecules       Date:  2021-04-23

Review 6.  DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons.

Authors:  Therese Wilhelm; Maha Said; Valeria Naim
Journal:  Genes (Basel)       Date:  2020-06-10       Impact factor: 4.096

7.  CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.

Authors:  Chunyan Gu; Wang Wang; Xiaozhu Tang; Tingting Xu; Yanxin Zhang; Mengjie Guo; Rongfang Wei; Yajun Wang; Artur Jurczyszyn; Siegfried Janz; Meral Beksac; Fenghuang Zhan; Anja Seckinger; Dirk Hose; Jingxuan Pan; Ye Yang
Journal:  Mol Cancer       Date:  2021-06-05       Impact factor: 27.401

8.  p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair.

Authors:  Victor Cy Mak; Xinran Li; Ling Rao; Yuan Zhou; Sai-Wah Tsao; Lydia Wt Cheung
Journal:  Neoplasia       Date:  2021-06-16       Impact factor: 5.715

9.  CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer.

Authors:  Jian Wang; Ruiguang Zhang; Zhenyu Lin; Sheng Zhang; Yaobing Chen; Jing Tang; Jiaxin Hong; Xiaoshu Zhou; Yan Zong; Yingzhuo Xu; Rui Meng; Shuangbing Xu; Li Liu; Tao Zhang; Kunyu Yang; Xiaorong Dong; Gang Wu
Journal:  J Hematol Oncol       Date:  2020-07-20       Impact factor: 17.388

10.  Poly Lactic-Co-Glycolic Acid- (PLGA-) Loaded Nanoformulation of Cisplatin as a Therapeutic Approach for Breast Cancers.

Authors:  Saad Alkahtani; Saud Alarifi; Gadah Albasher; Mohammed Al-Zharani; Nada H Aljarba; Mohammed H Almarzoug; Norah M Alhoshani; Norah S Al-Johani; Hani Alothaid; Abdullah A Alkahtane
Journal:  Oxid Med Cell Longev       Date:  2021-06-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.